OncoFusion Therapeutics Garners $525,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82220e69-9f98-4be2-a737-016dd908c294&Preview=1 -
Date
3/2/2013 -
Company Name
OncoFusion Therapeutics -
Mailing Address
1600 Huron Parkway 2nd Floor Ann Arbor, MI 48109 -
Company Description
OncoFusion Therapeutics, Inc. (Ann Arbor, MI) is an oncology discovery and development company targeting gene fusions that are thought to drive many common cancers. The technology is based on discoveries from the laboratories of the companies’ co-founders, Dr. Arul Chinnaiyan and Dr. Shaomeng Wang, at the University of Michigan. -
Website
http://www.oncofusion.com -
Transaction Type
Debt -
Transaction Amount
$525,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
